Nash clinical trials

Explore recruiting nash clinical trials.

Recruiting nash studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Nash trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomised, double-blind, placebo-controlled, multicentre, Phase 3 study evaluating efficacy and safety of lanifibranor followed by an active treatment extension in adult patient with non-cirrhotic non-alcoholic steatohepatitis (NASH) and fibrosis 2 (F2)/fibrosis 3 (F3) stage of liver fibrosis

Bulgaria, Germany, Spain, Poland, Portugal, Italy +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

17 β-Hydroxysteroid Dehydrogenase type 13 Minimization for the treatment of NASH (HORIZON): A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of GSK4532990 in Adults with Nonalcoholic Steatohepatitis

Greece, Italy, Belgium, Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2B Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)

Romania, Bulgaria, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

The effect of semaglutide in subjects with non-cirrhotic non-alcoholic steatohepatitis

Romania, Netherlands, Denmark, Poland, France, Ireland +12 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2b Randomized, Double-Blind Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Adults with Precirrhotic Nonalcoholic Steatohepatitis

Spain, Belgium, Austria, Czechia, Portugal, Italy +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy and safety investigation of NNC0194-0499 co-administered with semaglutide in subjects with non-alcoholic steatohepatitis: a dose-ranging, placebo-controlled trial.

Germany, France, Italy, Denmark, Spain, Poland +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Nash trials by city

Nash in Toronto Nash in Vancouver Nash in Montreal Nash in Calgary Nash in Edmonton Nash in Ottawa Nash in Winnipeg Nash in Quebec City Nash in Hamilton Nash in Kitchener Nash in London Nash in Halifax Nash in New York Nash in Los Angeles Nash in Chicago Nash in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease